Ana Maria Castaño Leon

Ana Maria Castaño Leon

Auto-generated profile, based on publicly available information

Ana Maria Castaño Leon

Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Spain

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The Lancet Neurology
Verified
Journal Article
Closed access
AMAndrew I R Maas
Andrew I R Maas
DMDavid K Menon
David K Menon
PAP David Adelson
P David Adelson
NANada Andelic
Nada Andelic
MBMichael J Bell
Michael J Bell
FZFabrizio Zumbo
Fabrizio Zumbo

1 October 2019 in The Lancet Neurology
Verified
Journal Article
Open access
ESEwout W Steyerberg
Ewout W Steyerberg
EWEveline Wiegers
Eveline Wiegers
CSCharlie Sewalt
Charlie Sewalt
ABAndras Buki
Andras Buki
GCGiuseppe Citerio
Giuseppe Citerio
TZTommaso Zoerle
Tommaso Zoerle
The burden of traumatic brain injury (TBI) poses a large public health and societal problem, but the characteristics of patients and their care pathways in Europe are poorly understood. We aimed to characterise patient case-mix, care pathways, and outcomes of TBI. CENTER-TBI is a Europe-based, observational cohort study, consisting of a core study and a registry. Inclusion criteria for the core study were a clinical diagnosis of TBI, presentation fewer than 24 h after injury, and an indication for CT. Patients were differentiated by care pathway and assigned to the emergency room (ER) stratum (patients who were discharged from an emergency room), admission stratum (patients who were admitted to a hospital ward), or intensive care unit (ICU) stratum (patients who were admitted to the ICU). Neuroimages and biospecimens were stored in repositories and outcome was assessed at 6 months after injury. We used the IMPACT core model for estimating the expected mortality and proportion with unfavourable Glasgow Outcome Scale Extended (GOSE) outcomes in patients with moderate or severe TBI (Glasgow Coma Scale [GCS] score ≤12). The core study was registered with ClinicalTrials.gov, number NCT02210221, and with Resource Identification Portal (RRID: SCR_015582). Data from 4509 patients from 18 countries, collected between Dec 9, 2014, and Dec 17, 2017, were analysed in the core study and from 22 782 patients in the registry. In the core study, 848 (19%) patients were in the ER stratum, 1523 (34%) in the admission stratum, and 2138 (47%) in the ICU stratum. In the ICU stratum, 720 (36%) patients had mild TBI (GCS score 13-15). Compared with the core cohort, the registry had a higher proportion of patients in the ER (9839 [43%]) and admission (8571 [38%]) strata, with more than 95% of patients classified as having mild TBI. Patients in the core study were older than those in previous studies (median age 50 years [IQR 30-66], 1254 [28%] aged >65 years), 462 (11%) had serious comorbidities, 772 (18%) were taking anticoagulant or antiplatelet medication, and alcohol was contributory in 1054 (25%) TBIs. MRI and blood biomarker measurement enhanced characterisation of injury severity and type. Substantial inter-country differences existed in care pathways and practice. Incomplete recovery at 6 months (GOSE <8) was found in 207 (30%) patients in the ER stratum, 665 (53%) in the admission stratum, and 1547 (84%) in the ICU stratum. Among patients with moderate-to-severe TBI in the ICU stratum, 623 (55%) patients had unfavourable outcome at 6 months (GOSE <5), similar to the proportion predicted by the IMPACT prognostic model (observed to expected ratio 1·06 [95% CI 0·97-1·14]), but mortality was lower than expected (0·70 [0·62-0·76]). Patients with TBI who presented to European centres in the core study were older than were those in previous observational studies and often had comorbidities. Overall, most patients presented with mild TBI. The incomplete recovery of many patients should motivate precision medicine research and the identification of best practices to improve these outcomes. European Union 7th Framework Programme, the Hannelore Kohl Stiftung, OneMind, and Integra LifeSciences Corporation.

15 August 2015 in Journal of Neurotrauma
Verified
Journal Article
Closed access
Santiago CepedaSantiago Cepeda
Santiago Cepeda
PGPedro A. Gómez
Pedro A. Gómez
ACAna María Castaño-Leon
Ana María Castaño-Leon
RMRafael Martínez-Pérez
Rafael Martínez-Pérez
PMPablo M. Munarriz
Pablo M. Munarriz
Alfonso LagaresAlfonso Lagares
Alfonso Lagares
The increase in the volume of a traumatic intracerebral hemorrhage (TICH) is a widely studied phenomenon that has a direct impact on the prognosis of patients. The objective of this study was to identify the risk factors associated with the progression of TICH. We retrospectively analyzed the records of 1970 adult patients >15 years of age who were consecutively admitted after sustaining a closed severe traumatic brain injury (TBI) between January 1987 and November 2013 at a single center. Beginning in 2007, patients with moderate TBIs were also included. A total of 782 patients exhibited one or more TICH on the initial CT scan, and met the selection criteria. The main outcome variable was the presence or absence of progression of the TICH. Univariate and multivariate statistical analyses were performed. Factors independently associated with the growth of TICH obtained through logistic regression included the following: an initial volume <5 cc (odds ratio [OR] 2.42, p <0.001), cisternal compression (OR 1.95, p <0.001), decompressive craniectomy (OR 2.18, p <0.001), age (mean 37.67 vs. 42.95 years; OR 1.01, p <0.001), falls as mechanism of trauma (OR 1.72, p =0.001), multiple TICHs (OR 1.56, p =0.007), and hypoxia (OR 1.56, p =0.02). TICH progression occurred with a frequency of 63% in our study. We showed that there was a correlation between TICH growth and some variables, such as multiple TICHs, a lower initial volume, acute subdural hematoma, cisternal compression, older patient age, hypoxia, falls, and decompressive craniectomy.

1 May 2015 in Neurocirugia
Verified
Journal Article
Closed access
IPIgor Paredes
Igor Paredes
ACAna María Castaño-León
Ana María Castaño-León
PMPablo M. Munarriz
Pablo M. Munarriz
RMRafael Martínez-Perez
Rafael Martínez-Perez
Santiago CepedaSantiago Cepeda
Santiago Cepeda
Alfonso LagaresAlfonso Lagares
Alfonso Lagares

1 April 2016 in World Neurosurgery
Verified
Journal Article
Closed access
PMPablo M. Munarriz
Pablo M. Munarriz
PGPedro A. Gómez
Pedro A. Gómez
IPIgor Paredes
Igor Paredes
ACAna M. Castaño-Leon
Ana M. Castaño-Leon
Santiago CepedaSantiago Cepeda
Santiago Cepeda
Alfonso LagaresAlfonso Lagares
Alfonso Lagares

1 December 2015 in Neurosurgery
Verified
Journal Article
Closed access
Alfonso LagaresAlfonso Lagares
Alfonso Lagares
LJLuis Jimenez-Roldan
Luis Jimenez-Roldan
PGPedro A. Gomez
Pedro A. Gomez
PMPablo M. Munarriz
Pablo M. Munarriz
ACAna M. Castaño-León
Ana M. Castaño-León
JAJosé F. Alén
José F. Alén
Quantitative estimation of the hemorrhage volume associated with aneurysm rupture is a new tool of assessing prognosis. To determine the prognostic value of the quantitative estimation of the amount of bleeding after aneurysmal subarachnoid hemorrhage, as well the relative importance of this factor related to other prognostic indicators, and to establish a possible cut-off value of volume of bleeding related to poor outcome. A prospective cohort of 206 patients consecutively admitted with the diagnosis of aneurysmal subarachnoid hemorrhage to Hospital 12 de Octubre were included in the study. Subarachnoid, intraventricular, intracerebral, and total bleeding volumes were calculated using analytic software. For assessing factors related to prognosis, univariate and multivariate analysis (logistic regression) were performed. The relative importance of factors in determining prognosis was established by calculating their proportion of explained variation. Maximum Youden index was calculated to determine the optimal cut point for subarachnoid and total bleeding volume. Variables independently related to prognosis were clinical grade at admission, age, and the different bleeding volumes. The proportion of variance explained is higher for subarachnoid bleeding. The optimal cut point related to poor prognosis is a volume of 20 mL both for subarachnoid and total bleeding. Volumetric measurement of subarachnoid or total bleeding volume are both independent prognostic factors in patients with aneurysmal subarachnoid hemorrhage. A volume of more than 20 mL of blood in the initial noncontrast computed tomography is related to a clear increase in poor outcome risk. : aSAH, aneurysmal subarachnoid hemorrhage.